Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004286 · ClinicalTrials.gov registry record
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
A clinical trial of Pain, sponsored by Defense and Veterans Center for Integrative Pain Management.
- Recruiting
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT04004286: Recruiting study of Pain, sponsored by Defense and Veterans Center for Integrative Pain Management.
NCT04004286 is a study of Pain that is actively recruiting participants, run by Defense and Veterans Center for Integrative Pain Management. The registered enrollment target is 300 participants, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04004286, a study of Pain, is actively recruiting participants, sponsored by Defense and Veterans Center for Integrative Pain Management.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
This Pain Registry Biobank is a prospective cohort design study whereby data (PASTOR survey, blood and saliva specimens, clinical data) is collected from participants in a longitudinal fashion with continual enrollment.
Primary Outcome
a thorough biopsychosocial assessment computer adaptive screening tool that extends beyond a single-item pain rating scale. PASTOR is an assessment battery that includes several Patient Reported Outcomes Measurement Information System (PROMIS) scales developed by the National Institutes of Health (NIH) and other important scales that span physical, psychological, social, and behavioral aspects of pain and pain-related treatments.
Conditions Studied
Study Locations (2)
California
- Naval Medical Center San Diego - San Diego
Maryland
- Walter Reed National Military Medical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2050-02 |
What NCT04004286 shows while recruiting
NCT04004286 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT04004286 reports a single indexed study location in California, Maryland.
Frequently Asked Questions
What is clinical trial NCT04004286 about?
NCT04004286 is a clinical study titled "Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank". This Pain Registry Biobank is a prospective cohort design study whereby data (PASTOR survey, blood and saliva specimens, clinical data) is collected from participants in a longitudinal fashion with continual enrollment.
What is the current status of trial NCT04004286?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2019-02-01. Estimated completion is 2050-02.
What conditions does trial NCT04004286 study?
This clinical trial studies the following conditions: Pain.
Who is sponsoring clinical trial NCT04004286?
This trial is sponsored by Defense and Veterans Center for Integrative Pain Management, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04004286 being conducted?
This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04004286's enrollment target sits among peer trials
300 57th of 374 higher than 315 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI